DAX19.885 -0,4%ESt504.862 -0,3%Top 10 Crypto15,18 +0,5%Dow42.840 +1,2%Nas19.573 +1,0%Bitcoin93.447 -0,2%Euro1,0434 +0,7%Öl72,98 +0,4%Gold2.621 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Novo Nordisk A3EU6F Tesla A1CX3T NVIDIA 918422 Volkswagen (VW) vz. 766403 Palantir A2QA4J MicroStrategy 722713 Amazon 906866 Apple 865985 Rheinmetall 703000 Bayer BAY001 Siemens Energy ENER6Y Allianz 840400 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Bank 514000 Microsoft 870747
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach Fed-Leitzinssenkung: DAX schließt unter 20.000 -- US-Börsen kaum verändert -- Rheinmetall erhält Milliarden-Aufträge -- Adnoc erreicht bei Covestro Squeeze-out-Grenze -- Micron, Douglas im Fokus
Top News
So bewegen sich die Preise von Gold, Öl, Silber und Weizen am Mittag So bewegen sich die Preise von Gold, Öl, Silber und Weizen am Mittag
So bewegen sich Bitcoin & Co. heute So bewegen sich Bitcoin & Co. heute
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Theralink Technologies Aktie

NeuKaufenVerkaufen
0,0001 USD ±0,0000 USD ±0,00 %
NASO
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

Marktkap.0,59 Mio. EUR

Div. Rendite0,00%

WKNA3DGG2

ISINUS88339Q1094

SymbolTHER

Theralink Technologies Aktien News

DatumMeistgelesen
PR NewswireTheralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
PR NewswireTheralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University
PR NewswireTheralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone
PR NewswireTheralink's Exclusive Licensed RPPA Technology for Commercial Laboratory Testing to Assist the White House Cancer Moonshot Initiative
PR NewswireTheralink® Technologies Appoints Michael Vallone as Senior Director of Commercialization
PR NewswireTheralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company
PR NewswireTheralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium
PR NewswireTheralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
PR NewswireTheralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U.S.
PR NewswireTheralink® Technologies Receives Final Medicare Reimbursement Rate Determination and PTAN Enrollment
PR NewswireTheralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory
PR NewswireTheralink® Technologies to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14
PR NewswireTheralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer
PR NewswireTheralink® Technologies to Host Fireside Chat with Dr. Mick Ruxin, President and Chief Executive Officer, on June 22nd at 11:00 a.m. ET
PR NewswireTheralink® Technologies Expands Adoption of its Precision Medicine Technology in the Biopharmaceutical Industry
PR NewswireAvera Health and Theralink® Technologies Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care
PR NewswireTheralink® Technologies Announces New PLA Code and Information Submittal to Medicare Contractors for the Theralink Assay for Advanced Breast Cancer Patients
PR NewswireEarly Results Show >90% Actionability and >75% Clinical Utility for Theralink® Technologies' Lab Developed Test for Advanced Breast Cancer Patients

Theralink Technologies News

Theralink Technologies News: auf dieser Seite finden Sie alle Theralink Technologies News und Nachrichten zur Theralink Technologies Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Theralink Technologies News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Theralink Technologies News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.